306936-00-5 Usage
Uses
Used in Pharmaceutical Industry:
5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drug molecules. Its unique structure allows for the creation of compounds with specific therapeutic properties, enhancing the range of available treatments.
Used in Agrochemical Industry:
In the agrochemical sector, 5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is utilized as a building block for the preparation of agrochemicals, potentially leading to the development of novel pesticides or other agricultural chemicals that can improve crop protection and yield.
Used in Materials Science:
5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is employed as a component in the creation of functional materials, where its distinct properties can be leveraged to develop new materials with specialized characteristics for various applications in materials science.
Used in Chemical Research and Development:
As a valuable tool in chemical research and development, 5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FURALDEHYDE is used for exploring new chemical reactions and synthesis pathways, contributing to the advancement of chemical knowledge and the discovery of innovative applications.
Check Digit Verification of cas no
The CAS Registry Mumber 306936-00-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,6,9,3 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 306936-00:
(8*3)+(7*0)+(6*6)+(5*9)+(4*3)+(3*6)+(2*0)+(1*0)=135
135 % 10 = 5
So 306936-00-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H7F3O3/c13-12(14,15)18-11-4-2-1-3-9(11)10-6-5-8(7-16)17-10/h1-7H
306936-00-5Relevant articles and documents
Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid
Pfefferkorn, Jeffrey A.,Greene, Meredith L.,Nugent, Richard A.,Gross, Rebecca J.,Mitchell, Mark A.,Finzel, Barry C.,Harris, Melissa S.,Wells, Peter A.,Shelly, John A.,Anstadt, Robert A.,Kilkuskie, Robert E.,Kopta, Laurice A.,Schwende, Francis J.
, p. 2481 - 2486 (2007/10/03)
A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase.
